Cyberonics to Present at Sidoti 16th Annual Emerging Growth Research Institutional Investor Forum
HOUSTON, March 6, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the Sidoti 16th Annual Emerging Growth Research Institutional Investor Forum on Tuesday, March 20, 2012, in New York.
Dan Moore, President & Chief Executive Officer, will speak at 10:40 AM Eastern Time. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM ET on Tuesday, March 20, 2012. This event will not be webcast.
About Cyberonics, Inc. and the VNS Therapy® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.
Greg Browne, CFO
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332
SOURCE Cyberonics, Inc.